Diagnostic comparison of 18F-FDG with 18F-FAPI-74 in Thyroid Cancer patients with TENIS Syndrome
Phase 1
- Conditions
- Imaging comparison of the drug under investigation on thyroid cancer patients with TENIS syndromeTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2021-002904-11-CY
- Lead Sponsor
- GERMAN ONCOLOGY CENTER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Thyroid cancer patients with TENIS syndrome
Older than 18
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5
Exclusion Criteria
Pregnant
Non-consented
Simultaneously other tumors
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method